This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
Bayer now present in four of the largest biotechnology hubs in the United States
The presentations will showcase previously undisclosed data highlighting the expanding potential of Actinium’s Ac-225 radiotherapy platform across both solid tumors and hematologic malignancies
Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addressing chronic inflammation
The company also revealed that MK-2214 has received Fast Track Designation from the U.S. Food and Drug Administration
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
New funding to advance non-surgical brain interface technology and expand clinical and engineering capabilities globally
Subscribe To Our Newsletter & Stay Updated
